Arecor Therapeutics PLC (AREC) — Cash Flow Quality Index
Latest as of December 2025:
-0.33x
Arecor Therapeutics PLC (AREC) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of GBX-1.15 Million is below net income of GBX3.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AREC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.33x
Operating CF / Net Income
Operating Cash Flow
GBX-1.15 Million
GBX
Net Income
GBX3.44 Million
GBX
Data as of
Dec 2025
Most recent filing
Arecor Therapeutics PLC Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Arecor Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see AREC cash flow metrics.
Annual Cash Flow Quality Index for Arecor Therapeutics PLC (2025–2025)
Year-by-year earnings quality comparison for Arecor Therapeutics PLC.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -2.46x | GBX-2.29 Million | GBX932.00K | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.